E-LIB Suche - Ergebnisse für: Aksu, Kurtuluş

1

Hypersensitivity reactions with first-line antituberculosis..:

Koycu Buhari, Gozde ; Oner Erkekol, Ferda ; Koca Kalkan, Ilkay...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793166/. , 2024

Link: http://www.ncbi.nlm.nih...

2

What is the Best Way to Diagnose Possible Asthma Patients w..:

Başa Akdoğan, Buket ; Koca Kalkan, Ilkay ; Köycü Buhari, Gözde...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JAA.S437756. , 2024

Link: https://www.dovepress.co..

3

Challenges and recommendations for the management of asthma..:

Zeitouni, Mohamed Omar ; Al-Moamary, Mohamed Saad ; Coussa, Marie Louise...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150662/. , 2022

Link: http://www.ncbi.nlm.nih...

4

Short-acting beta(2)-agonist prescription patterns in patie..:

Aksu, Kurtulus ; EDİGER, DANE ; Yorgancioglu, Arzu...
cf9a5ef4-4d36-4927-b033-bbc18156563e. , 2022

Link: https://doi.org/10.1186/..

5

Short-acting β(2)-agonist prescription patterns in patients..:

Yorgancıoğlu, Arzu ; Aksu, Kurtuluş ; Naycı, Sibel Atış...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161536/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Short-acting β2-agonist prescription patterns in patients w..:

Aksu, Funda ; Baççıoğlu, Ayşe ; Kalpaklıoğlu, Füsun...
cf9a5ef4-4d36-4927-b033-bbc18156563e. , 2022

Link: https://doi.org/10.1186/..

7

Identification of Risk Factors and Cross-Reactivity of Loca..:

Koca Kalkan, Ilkay ; Koycu Buhari, Gozde ; Ates, Hale...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837570/. , 2021

Link: http://www.ncbi.nlm.nih...

8

COVID-19 in a patient with severe asthma using mepolizumab:

Aksu, Kurtuluş ; Yesilkaya, Selma ; Topel, Musa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133013/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Identification of Risk Factors and Cross-Reactivity of Loca..:

Koca Kalkan, Ilkay ; Koycu Buhari, Gozde ; Ates, Hale...
info:eu-repo/semantics/altIdentifier/doi/10.2147/JAA.S292442. , 2021

Link: https://www.dovepress.co..

10

Programmed death ligand 1 expression levels, clinicopatholo..:

Agackiran, Yetkin ; Aksu, Funda ; Akyurek, Nalan...
http://arxiv.org/abs/2011.05862. , 2020

Link: http://arxiv.org/abs/201..

11

Clinical, sociodemographic and tobacco-use factors associat..:

Esmer, Bilgen ; Sengezer, Tijen ; Aksu, Funda..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205083/. , 2019

Link: http://www.ncbi.nlm.nih...

12

Inflammatory markers in exhaled breath condensate in patien..:

GÜNDÜZ, EREN ; KURT, EMEL ; AKSU, KURTULUŞ..
0271133b-0d1c-48b0-a364-9376c017a340. , 2012

Link: https://doi.org/10.5578/..

13

Challenges and recommendations for the management of asthma..:

Mohamed Omar Zeitouni ; Mohamed Saad Al-Moamary ; Marie Louise Coussa...
http://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2022;volume=17;issue=2;spage=71;epage=80;aulast=Zeitouni. , 2022

Link: https://doi.org/10.4103/..

14

Short-acting β2-agonist prescription patterns in patients w..:

Arzu Yorgancıoğlu ; Kurtuluş Aksu ; Sibel Atış Naycı...
https://doi.org/10.1186/s12890-022-02008-9. , 2022

Link: https://doi.org/10.1186/..

15

Changes in Treatment Adherence During the COVID-19 Pandemic..:

Şenay Demir ; Sakine Nazik Bahçecioğlu ; Hale Ateş...
https://dergipark.org.tr/tr/download/article-file/2623295. , 2022

Link: https://doi.org/10.16899..